Mersana Therapeutics, Inc.·4

Jun 13, 4:57 PM ET

Hege Kristen 4

4 · Mersana Therapeutics, Inc. · Filed Jun 13, 2025

Insider Transaction Report

Form 4
Period: 2025-06-12
Hege Kristen
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-12+61,50061,500 total
    Exercise: $0.36Exp: 2035-06-11Common Stock (61,500 underlying)
Footnotes (1)
  • [F1]The award will vest in full on the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continuous service with the Issuer on such vesting date.

Documents

1 file
  • 4
    tm2517941-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT